GlassScriptPhysician profile
Arial J Dunson
NPI 1154710549
$7,750.37
in general payments reported to CMS, 2019-2025
35 companies · $1,802 in 2025
The $1,802 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,243 · 2022: $1,147 · 2023: $1,627 · 2024: $1,931 · 2025: $1,802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,360.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,415.84 | 2021-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $1,333.60 | 2021-2025 | Xtampza, Belbuca, Nucynta |
| Abbvie INC. | $1,189.83 | 2021-2025 | |
| Forte Bio-Pharma LLC | $591.40 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Scilex Pharmaceuticals INC. | $571.47 | 2021-2025 | Ztlido |
| Boston Scientific Corporation | $476.74 | 2021-2025 | Intracept, General - Pain Management |
| Protega Pharmaceutials INC | $385.50 | 2024-2025 | Roxybond |
| Biotronik Nro, INC. | $329.83 | 2023-2024 | Prospera, Biotronik |
| Ibsa Pharma INC. | $222.81 | 2021-2025 | Tirosint, Licart, Licart |
| Pfizer INC. | $145.38 | 2023-2025 | |
| Nalu Medical, INC. | $132.34 | 2021-2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $113.65 | 2022-2025 | Intellis Adaptivestim, Vanta Adaptivestim |
| Lilly USA, LLC | $83.66 | 2021-2024 | Emgality, Reyvow |
| Grt US Holding, INC. | $67.53 | 2021-2022 | |
| Redhill Biopharma INC. | $65.35 | 2021-2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $61.23 | 2022-2024 | Sprint Pns System |
| Nevro Corp. | $53.31 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $49.71 | 2021 | |
| Amgen INC. | $48.96 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $43.48 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $36.93 | 2024-2025 | |
| Abbott Laboratories | $34.46 | 2023-2024 | Proclaim, Eterna |
| Painteq LLC | $32.59 | 2023-2024 | Painteq |
| Tonix Medicines, INC. | $29.32 | 2025 | Tonmya |
| Neuronetics, INC. | $27.82 | 2023 | Neurostar Tms Therapy System |
| Otsuka America Pharmaceutical, INC. | $27.42 | 2023 | Rexulti, Abilify Maintena |
| Pacira Pharmaceuticals Incorporated | $26.19 | 2025 | Zilretta |
| Axsome Therapeutics, INC. | $24.23 | 2025 | Symbravo |
| Stimwave Technologies Incorporated | $23.88 | 2021 | |
| Averitas Pharma INC. | $23.46 | 2025 | Qutenza |
| Globus Medical, INC. | $22.25 | 2025 | Vyrsa V1 |
| Saluda Medical Americas, INC. | $21.44 | 2023 | Evoke Scs |
| Impel Pharmaceuticals INC. | $13.39 | 2023 | Trudhesa |
| Arbor Pharmaceuticals, INC. | $13.01 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arial Dunson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.